Materials Healthcare Sector

Celularity

Market Cap: US$54.8m

A clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases.

Biomind Labs

Market Cap: US$54.3m

A biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions.

Onco-Innovations

Market Cap: CA$74.5m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

United Health Products

Market Cap: US$54.0m

Develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States.

Covalon Technologies

Market Cap: CA$74.0m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Outlook Therapeutics

Market Cap: US$53.7m

Operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications.

Odonate

Market Cap: US$53.3m

A pharmaceutical company, develops therapeutics for the treatment of cancer.

Cytosorbents

Market Cap: US$52.9m

Engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally.

Beamtree Holdings

Market Cap: AU$81.1m

Provides artificial intelligence-based decision support software and data insight services to healthcare industry in Australia and internationally.

Hydreight Technologies

Market Cap: CA$72.2m

Provides mobile health and wellness services primarily in the United States.

Fortress Biotech

Market Cap: US$52.6m

A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.

Cyberfuels Holding

Market Cap: US$52.5m

Operates as an energy and healthcare company in the United States.

P3 Health Partners

Market Cap: US$52.4m

A patient-centered and physician-led population health management company, provides superior care services in the United States.

Kalaris Therapeutics

Market Cap: US$52.2m

A clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases.

Singular Health Group

Market Cap: AU$80.3m

A medical technology company, engages in the development and commercialization of volumetric rendering platform (VRP) and software development in Australia.

MAIA Biotechnology

Market Cap: US$51.8m

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.

Shattuck Labs

Market Cap: US$51.7m

A biotechnology company, develops antibodies for the treatment of inflammatory and immune-mediated diseases.

Werewolf Therapeutics

Market Cap: US$51.6m

A biopharmaceutical company, engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions.

Actinium Pharmaceuticals

Market Cap: US$51.2m

Develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Ondine Biomedical

Market Cap: UK£37.7m

A life-sciences company, engages in the development and commercialization of treat infections, and drug-resistant pathogens antimicrobial therapies in Canada and internationally.

VolitionRx

Market Cap: US$51.0m

A multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally.

Born

Market Cap: US$50.8m

Does not have significant operations.

Beroni Group

Market Cap: AU$75.9m

Develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally.

Quince Therapeutics

Market Cap: US$50.5m

A biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.

SafeSpace Global

Market Cap: US$50.1m

Through its subsidiaries, develops healthcare technology solutions to enhance safety and streamline operations in hospitals, schools, transportation hubs, and industrial sites in the United States.

Prelude Therapeutics

Market Cap: US$50.0m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

Gain Therapeutics

Market Cap: US$50.0m

A biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.

Biodesix

Market Cap: US$50.0m

Operates as a diagnostic solutions company.

Cue Biopharma

Market Cap: US$49.8m

A clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States.

Positron

Market Cap: US$49.5m

A nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States.

Recce Pharmaceuticals

Market Cap: AU$76.0m

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.

bluebird bio

Market Cap: US$48.9m

A biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States.

Century Therapeutics

Market Cap: US$48.1m

A clinical-stage biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases.

Reviva Pharmaceuticals Holdings

Market Cap: US$48.1m

A biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases.

Precision BioSciences

Market Cap: US$48.0m

A clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States.

HST Global

Market Cap: US$48.0m

Operates as an integrated health and wellness biotechnology company in the United States.